Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3776694016 | Risankizumab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3776695015 | Risankizumab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Risankizumab | est un(e) (attribut) | Substance with interleukin 23 receptor antagonist mechanism of action (substance) | true | Inferred relationship | Some | ||
| Risankizumab | Has disposition (attribute) | Interleukin 23 receptor antagonist (disposition) | true | Inferred relationship | Some | ||
| Risankizumab | est un(e) (attribut) | anticorps monoclonal chimérique souris-humain d'isotype IgG | false | Inferred relationship | Some | ||
| Risankizumab | est un(e) (attribut) | Immunosuppressant (substance) | true | Inferred relationship | Some | ||
| Risankizumab | est un(e) (attribut) | Monoclonal antibody (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing risankizumab (medicinal product) | a pour principe actif (attribut) | True | Risankizumab | Inferred relationship | Some | 1 |
| Risankizumab-containing product in parenteral dose form | a pour principe actif (attribut) | True | Risankizumab | Inferred relationship | Some | 1 |
| Risankizumab only product in parenteral dose form | a pour principe actif (attribut) | True | Risankizumab | Inferred relationship | Some | 1 |
| Risankizumab only product | a pour principe actif (attribut) | True | Risankizumab | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR